At BioSpectrum Ltd, we specialise in bringing the most innovative medical devices to the UK healthcare market. From our modern offices and warehouse in the historic market town of Newark, Nottinghamshire, we work with trusted partners to deliver technology that makes a real difference to patient outcomes.
Unlike large multinational corporations, we operate with a lean, agile structure. That means we can offer high-quality products at competitive prices—without compromising on standards.
Our commitment to service is at the very core of our business. We believe that being a smaller company means we can work harder for our customers. Our dedicated Customer Services team is passionate about delivering excellence—first time, every time.
If your hospital is looking for cost-effective access to cutting-edge medical devices delivered by a reliable partner with responsive support, BioSpectrum is here to help.
Get in touch today to see how our carefully selected product portfolio and customer-focused approach can support your hospital and improve care for your patients.
BioSpectrum Ltd, a fast-growing UK distributor of surgical solutions in the field of Urology, Gynaecology and General Surgery, has joined the AddLife group and will form part of AddLife’s Business Area Medtech.
Joining AddLife represents an important step in BioSpectrum’s continued development. The partnership provides access to the wider expertise, resources and European network of the AddLife Group, creating new opportunities to further expand BioSpectrum’s offering and strengthen support for healthcare providers across the UK.
“We are very excited about the new opportunities, experience and resources that AddLife brings to BioSpectrum. This move offers a truly long-term perspective for our employees and supports the continued expansion of the company. Being part of the larger AddLife Group, with its strong European presence and deep expertise in hospital markets, is an important milestone for our employees, suppliers and customers as we continue to develop and grow” – Adam McQuilkin, Founder and Managing Director of BioSpectrum.
This agreement was signed and took effect on 11 March 2026.
© / BioSpectrum Ltd. All Rights Reserved. Designed by Webcapitan.
